AgaMatrix | Innovative Products for Diabetes Care
Comparison of Automated Insulin Delivery Systems - Diabetesnet.com
AgaMatrix & WaveForm Complete $56 Million Capital Raise
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections | Diabetes Technology & Therapeutics
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections | Diabetes Technology & Therapeutics
Reorganization, and Formation of WaveForm Technologies Inc.
WaveForm Gets Favorable Decision on Glucose Monitoring Patents
Glucose Meters | AgaMatrix
Reorganization, and Formation of WaveForm Technologies Inc.
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
Diabetes Technology Society
Federal Judge Awards AgaMatrix While Admonishing Dexcom
Oregon medical device maker raises $56M - Portland Business Journal
Improving HbA1c levels with advanced hybrid closed-loop therapy - The Lancet Diabetes & Endocrinology
Opportunities and challenges in closed-loop systems in type 1 diabetes - The Lancet Diabetes & Endocrinology
AgaMatrix Announces Reorganization, and Formation of WaveForm Technologies Inc.
Bayer, WaveForm in tie-up for glucose monitoring solutions for China - Chinadaily.com.cn
Update and Advances in Technology For Diabetes Self Management PDF | PDF | Diabetes Mellitus | Mobile App
AgaMatrix Announces Reorganization, and Formation of WaveForm Technologies Inc.
Glucose Meters | AgaMatrix
About | Waveform
Reorganization, and Formation of WaveForm Technologies Inc.
Hacking Diabetes - #wearenotwaiting
